DBVT Q2 2023 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$2M100.0% margin

Operating Income

-$25M-1096.0% margin

Net Income

-$24M-1059.6% margin

EPS (Diluted)

$-1.30

QoQ Revenue Growth

+4.3%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$218M

Total Liabilities

$53M

Stockholders' Equity

$164M

Cash & Equivalents

$174M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$2M	-$5M	+143.4%
Operating Income	-$25M	-$25M	+0.4%
Net Income	-$24M	-$23M	-5.9%